DR REDDY'S MAY LAND A MAJOR ROLE IN PLAVIX PATENT PLAY

With the block-the-sale request filed by Bristol-Myers Squibb (BMS) and partner Sanofi-Aventis against Apotex's brazen launch of generic 'Plavix' coming up for hearing on Friday at the US district court for the southern district of New York, the Indian angle to the unravelling drama is coming into focus. The Economic Times (http://economictimes.indiatimes.com/articleshow/1902415.cms)